$0.73 0.04 (+5.84%)
2/10/2012 3:59 PM

Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Featured Broker Partners


Advertisement